Patent ID: 8604021

Claim:
A method of treating a 5-HT-related condition, comprising administering an effective amount of a compound having the formula or pharmaceutically acceptable salts and/or esters thereof, wherein n is 1; A, is a lower alkyl group; R 1 is hydrogen or substituted or unsubstituted alkyl or aryl; R 2 is halo; cyano, lower alkoxy; carboxylate salt acid or alkyl ester thereof; haloalkyl or haloalkoxy; acetaldehyde; carboxamide; carbonyl —C(O)CF 3 , alkoxyaminocarbonyl substituted arylalkylamino, or SO 2 R 6 where R 6 may be substituted or unsubstituted alkyl or haloalkyl; R 3 and R 4 independently are hydrogen, substituted or unsubstituted alkyl, aryl, alkylaryl, heteroaryl or alkylheteroaryl, or, taken together, R 3 and R 4 form one substituted or unsubstituted aryl, alkylaryl, heteroaryl or alkylheteroaryl group; B, when present, is lower alkylene; and X and Y are —CH—.